You have 9 free searches left this month | for more free features.

gemcitabine

Showing 1 - 25 of 1,157

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Trial in Hangzhou (Canagliflozin and Gemcitabine, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer
  • Canagliflozin and Gemcitabine
  • Gemcitabine
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Jun 11, 2023

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Gemcitabine
  • +2 more
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Ovarian Cancer, Platinum-resistant Ovarian Cancer Trial in Minsk (Gemcitabine, ELENAGEN)

Active, not recruiting
  • Ovarian Cancer
  • Platinum-resistant Ovarian Cancer
  • Gemcitabine
  • ELENAGEN
  • Minsk, Belarus
    Minsk City Clinical Oncology Center
Jul 27, 2023

Cholangiocarcinoma Trial in Houston (Pembrolizumab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Cholangiocarcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2023

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Gemcitabine
  • Nab paclitaxel
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Gemcitabine
  • +2 more
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

Locally Advanced Cervical Cancer, Gemcitabine, Chemo-radiotherapy Trial in México (Gemcitabine, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • +2 more
  • México, Ciudad De México, Mexico
    National Cancer Institute of Mexico
Nov 27, 2023

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Gemcitabine
  • +3 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Aug 29, 2023

Urinary Bladder Cancer Trial in Tucson (Gemcitabine)

Not yet recruiting
  • Urinary Bladder Cancer
  • Gemcitabine
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 21, 2022

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Gemcitabine
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023

Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

Not yet recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 31, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
May 3, 2023

Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)

Active, not recruiting
  • Pancreatic Cancer
  • Gemcitabine
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jan 9, 2023

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Gemcitabine
  • supportive care
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Gemcitabine
  • +3 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Apr 11, 2023

Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)

Recruiting
  • Cholangiocarcinoma Non-resectable
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Aug 4, 2023

Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • Mesothelioma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023

Pancreatic Cancer Trial in New York (Canakinumab, Tislelizumab, Nab-Paclitaxel)

Recruiting
  • Pancreatic Cancer
  • New York, New York
  • +2 more
Aug 2, 2023

Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)

Recruiting
  • Soft Tissue Sarcoma
  • Gemcitabine
  • +4 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 26, 2023

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Dec 5, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

Active, not recruiting
  • Pancreatic Cancer
  • Pancreatic Ductal Adenocarcinoma
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Nov 29, 2022

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022